ABSTRACT

Paracoccidioidomycosis (PCM) is the most important systemic mycosis in Brazil, and it is widespread throughout Latin America. An estimated 10 million individuals are infected, with about 2% developing the disease. This mycosis has also been reported among patients with AIDS in Latin America. PCM presents several clinical forms, ranging from a localized and benign disease to a progressive and potentially lethal systemic infection. All patients from whom the fungus is isolated should be treated, and pulmonary fibrosis is still a common sequel, despite the availability of new antifungal drugs for therapy. Read more. . .